LifeSciences BC Blakes Breakfast Speaking Event

This Breakfast Speaking Series is proudly presented by:

LifeSciences BC was pleased to announce the Blakes Breakfast Speaking Event for Thursday, September 27, 2018.

The Blakes Breakfast Speaking Series is our longest-standing event series and one of our most popular. Held four times a year, these breakfasts include presentations by local, national and multinational life science companies and typically attract a cross-section of approximately 60 of our life sciences community members. The Breakfast Speaking Series is proudly presented by Blake, Cassels & Graydon LLP.

Keynote Presentation: “Pfizer’s Innovation Ecosystem – Breakthrough Impact for Patients”

Dr. Arpita Maiti, Senior Director, External Science & Innovation (ES&I), Inflammation & Immunology and Microbiome at Pfizer Boston

Pfizer engages in flexible partnership models that include research collaborations, venture capital investments, academic alliances for drug development, early-stage seed funding, establishing incubators, licensing, and spinning out of companies. Their externally-focused scientific team of high-profile PhDs/MDs, embedded within their research groups – identifies late-breaking science that forms the basis of innovative therapies and drives collaborations that are aimed at delivering value to Pfizer, their partners, and patients.

Dr. Arpita Maiti joined us to discuss Pfizer’s partnering models and their breakthrough impact for patients.

Speakers:

Tamer Mohamed, CEO at Aspect Biosystems

Dr. Michael Gallo, President of Innovative Targeting Solutions